CompanyDrug

CanSino Biologics’ Inhalable COVID-19 Vaccine Authorized in Morocco

CompanyDrug

Luye Pharma’s Biosimilar LY06006/BA6101 Approved for Osteoporosis Treatment

CompanyDrug

Lundbeck’s Eptinezumab Launches in Boao Lecheng for Migraine Treatment

CompanyDeals

Novartis Partners with Alibaba Health to Enhance Patient Medication Accessibility

CompanyDrug

RemeGen’s Telitacicept Set for Breakthrough Therapy Designation in Myasthenia Gravis

CompanyDeals

Harbour BioMed and Moderna Ink Licensing Deal for Oncology Immunotherapies

CompanyDrug

CStone’s PD-L1 Inhibitor Sugemalimab Achieves Primary Endpoint in Gastric Cancer Study

CompanyDrug

BeiGene’s Brukinsa Receives Marketing Approval in Brazil

CompanyDrug

Fujian Cosunter Receives Multiple Patents for Cancer and Hepatitis Drugs

CompanyDrug

Sinocelltech’s SCTV01E Vaccine Receives NMPA Approval for Phase II Study

CompanyDrug

3SBio’s Thrombopoietin Study in Pediatric ITP Reaches Primary Endpoint

CompanyDeals

Zenas BioPharma Completes $118M Series B Financing to Advance Obexelimab